Clinical factors associated with early readmission among acutely decompensated heart failure patients

Archives of Medical Science

Volumn 12, Issue 3, 2016, Pages 538-545

  Pierre Louis, Bredy ^a   Rodriques, Shareen ^b   Gorospe, Vanessa ^c   Guddati, Achuta K ^d   Aronow, Wilbert S ^e   Ahn, Chul ^f   Wright, Maurice ^a  

^a Harlem Hospital Center ^*  (United States)

^b St Mary's Medical Center Huntington   (United States)

^c HARTFORD HOSPITAL   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Congestive heart failure; Heart failure readmission; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

ACUTE HEART FAILURE; ADULT; AFRICAN AMERICAN; ARTICLE; ATRIAL FIBRILLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEW YORK; RETROSPECTIVE STUDY; SCORING SYSTEM; SUBSTANCE ABUSE; SYSTOLIC HEART FAILURE;

EID: 84973443312     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2016.59927     Document Type: Article

References (53)

1. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994;13:S107-12.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127:e6-245.
3. Bahrami H, Kronmal R, Bluemke DA, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med 2008;168:2138-45.
4. Wolinsky FD, Smith DM, Stump TE, Overhage JM, Lubitz RM. The sequelae of hospitalization for congestive heart failure among older adults. J Am Geriatr Soc 1997;45:558-63.
5. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-25.
6. Yancy CW. Heart failure in African Americans: a cardiovascular engima. J Card Fail 2000;6:183-6.
7. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol 1993;22:14A-9A.
8. Yancy CW, Strong M. The natural history, epidemiology, and prognosis of heart failure in African Americans. Congest Heart Fail 2004;10:15-8; quiz 21-2.
9. Bagchi AD, Stewart K, McLaughlin C, Higgins P, Croghan T. Treatment and outcomes for congestive heart failure by race/ethnicity in TRICARE. Med Care 2011;49:489-95.
10. Rodriguez F, Joynt KE, Lopez L, Saldana F, Jha AK. Readmission rates for Hispanic Medicare beneficiaries with heart failure and acute myocardial infarction. Am Heart J 2011;162:254-61 e3.
11. Joynt KE, Orav EJ, Jha AK. Thirty-day readmission rates for Medicare beneficiaries by race and site of care. JAMA 2011;305:675-81.
12. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-28.
13. Mehra MR. From crisis intervention to preventive intervention. A new approach to the management of heart failure. Tex Heart Inst J 1998;25:251-4.
14. Kocher RP, Adashi EY. Hospital readmissions and the Affordable Care Act: paying for coordinated quality care. JAMA 2011;306:1794-5.
15. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 1988;148:2013-6.
16. Satpathy C, Mishra TK, Satpathy R, Satpathy HK, Barone E. Diagnosis and management of diastolic dysfunction and heart failure. Am Fam Physician 2006;73:841-6.
17. Grossman W. Defining diastolic dysfunction. Circulation 2000;101:2020-1.
18. Naqvi TZ. Diastolic function assessment incorporating new techniques in Doppler echocardiography. Rev Cardiovasc Med 2003;4:81-99.
19. Heart Failure Society; Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010;16:e1-194.
20. Cohn JN, Tam SW, Anand IS, et al. Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT. J Card Fail 2007;13:331-9.
21. De Miguel Diez J, Chancafe Morgan J, Jimenez Garcia R. The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis 2013;8:305-12.
22. Padeletti M, Jelic S, LeJemtel TH. Coexistent chronic obstructive pulmonary disease and heart failure in the elderly. Int J Cardiol 2008;125:209-15.
23. Westert GP, Lagoe RJ, Keskimaki I, Leyland A, Murphy M. An international study of hospital readmissions and related utilization in Europe and the USA. Health Policy 2002;61:269-78.
24. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 2007;49:171-80.
25. Arshad A, Bansal A, Patel RC. Cardiac complications of human immunodeficiency virus infection: diagnos tic and therapeutic considerations. Heart Dis 2000;2:133-45.
26. Sani MU, Okeahialam BN, Aliyu SH, Enoch DA. Human immunodeficiency virus (HIV) related heart disease: a review. Wien Klin Wochenschr 2005;117:73-81.
27. Herzog CA, Asinger RW, Berger AK, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011;80:572-86.
28. Franczyk-Skora B, Gluba A, Olszewski R, et al. Heart function disturbances in chronic kidney disease-echocardiographic indices. Arch Med Sci 2014;10:1109-16.
29. Bielecka-Dabrowa A, Von Haehling S, Aronow WS, et al. Heart failure biomarkers in patients with dilated cardiomyopathy. Int J Cardiol 2013;168:2404-10.
30. Larned JM, Raja Laskar S. Atrial fibrillation and heart failure. Congest Heart Fail 2009;15:24-30.
31. Koitabashi T, Inomata T, Niwano S, et al. Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J 2005;69:823-30.
32. Patel K, Sui X, Zhang Y, et al. Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events. Int J Cardiol 2013;168:1905-9.
33. Alagiakrishnan K, Banach M, Jones LG, et al. Medication management of chronic heart failure in older adults. Drugs Aging 2013;30:765-82.
34. Alagiakrishnan K, Banach M, Jones LG, et al. Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults. Ann Med 2013;45:37-50.
35. McNamara DM. Pharmacogenetics in heart failure: genomic markers of endothelial and neurohumoral function. Congest Heart Fail 2004;10:302-8.
36. Franciosa JA, Ferdinand KC, Yancy CW, Consensus Statement on Heart Failure in African Americans Writing G. Treatment of heart failure in African Americans: a consensus statement. Congest Heart Fail 2010;16:27-38.
37. Bibbins-Domingo K, Fernandez A. BiDil for heart failure in black patients: implications of the U. S. Food and Drug Administration approval. Ann Intern Med 2007;146:52-6.
38. Chatterjee K, Massie B. Systolic and diastolic heart failure: differences and similarities. J Card Fail 2007;13:569-76.
39. Sarraf M, Masoumi A, Schrier RW. Cardiorenal syndrome in acute decompensated heart failure. Clin J Am Soc Nephrol 2009;4:2013-26.
40. Masoudi FA, Rathore SS, Wang Y, et al. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation 2004;110:724-31.
41. Echemann M, Zannad F, Briancon S, et al. Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study. Am Heart J 2000;139:624-31.
42. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35.
43. Frishman WH, Del Vecchio A, Sanal S, Ismail A. Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Dis 2003;5:253-71.
44. Hawkins NM, Jhund PS, McMurray JJ, Capewell S. Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail 2012;14:138-46.
45. Jones CA, Perera A, Chow M, Ho I, Nguyen J, Davachi S. Cardiovascular disease risk among the poor and homeless - what we know so far. Curr Cardiol Rev 2009;5:69-77.
46. Foraker RE, Rose KM, Suchindran CM, Chang PP, McNeill AM, Rosamond WD. Socioeconomic status, Medicaid coverage, clinical comorbidity, and rehospitalization or death after an incident heart failure hospitalization: Atherosclerosis Risk in Communities Cohort (1987 to 2004). Circulation Heart Fail 2011;4:308-16.
47. Rathore SS, Masoudi FA, Wang Y, et al. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 2006;152:371-8.
48. Ingelsson E, Lind L, Arnlov J, Sundstrom J. Socioeconomic factors as predictors of incident heart failure. J Card Fail 2006;12:540-5.
49. Sui X, Gheorghiade M, Zannad F, Young JB, Ahmed A. A propensity matched study of the association of education and outcomes in chronic heart failure. Int J Cardiol 2008;129:93-9.
50. Philbin EF, DiSalvo TG. Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol 1999;33:1560-6.
51. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990;38:1290-5.
52. Calvillo-King L, Arnold D, Eubank KJ, et al. Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systematic review. J Gen Intern Med 2013;28:269-82.
53. Ketchum ES, Levy WC. Multivariate risk scores and patient outcomes in advanced heart failure. Congest Heart Fail 2011;17:205-12.